600998.SH
Jointown Pharmaceutical Group Co., Ltd.
SSE · Healthcare · Medical - Distribution · CN
CNY 5.15
+0.98%Year over year
Reported trailing growth
- Revenue
- +7.0%
- EBITDA
- —
- EBIT
- -33.9%
- EPS
- -32.9%
- Free cash flow
- +9.5%
- Operating cash flow
- +9.9%
Forward estimates
Based on analyst estimates
- Revenue
- +8.7%
- EBITDA
- +47.4%
- EPS
- +31.8%
Three-year CAGR
- Revenue
- +4.7%
- EBITDA
- +4.7%
- EBIT
- +5.0%
- Net income
- +2.6%
- EPS
- -4.8%
- Free cash flow
- -9.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026